论文部分内容阅读
目的方法结果结论探讨微创小梁切除术联合微创晶状体超声乳化吸出术治疗新生血管性青光眼的临床效果。2007年12月至2009年1月于我院住院治疗的新生血管性青光眼16例16眼,手术方法为先通过两个0.7毫米的透明角膜穿刺口完成微创晶状体超声乳化吸出术,再于上方结膜切口下切除2m中层角巩膜条带,周边虹膜切除及前房成形后球结膜连续缝合。观察记录手术前后眼压、前房、视力变化及滤过泡情况。随访时间6-12个月,术眼手术后眼压均低于21mmHg,滤过泡形成良好,虹膜新生血管大多消褪,全部眼球得以保留,其中11例视力保持不变,5例不同程度提高。微创小梁切除术联合微创晶状体超声乳化吸出术是治疗新生血管性青光眼的一种有效方法mm×2.5m。
Objective To evaluate the clinical efficacy of minimally invasive trabeculectomy combined with minimally invasive phacoemulsification in the treatment of neovascular glaucoma. From December 2007 to January 2009 in our hospital for treatment of neovascular glaucoma in 16 cases 16 cases, the first surgical method is through two 0.7 mm clear corneal puncture completed minimally invasive phacoemulsification surgery, and then in the top Conjunctival incision 2m middle angle sclera excision, peripheral iridotomy and anterior chamber forming conjunctiva after continuous suture. Observation before and after recording intraocular pressure, anterior chamber, changes in visual acuity and filtration bleb conditions. The follow-up time ranged from 6 to 12 months. The intraocular pressure was lower than 21mmHg after surgery. The formation of filtration bleb was good. Most of the iris neovascularization faded away, and all the eyes were preserved. Eleven eyesight remained the same in 5 cases . Minimally invasive trabeculectomy combined with minimally invasive phacoemulsification is an effective method for the treatment of neovascular glaucoma mm × 2.5m.